Castle Biosciences, Inc.
CSTL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$501 | $4,523 | -$25,848 | $9,590 |
| Dep. & Amort. | $3,816 | $3,414 | $29,764 | $5,768 |
| Deferred Tax | $116 | -$4,667 | -$770 | -$2,307 |
| Stock-Based Comp. | $0 | $11,208 | $11,179 | $11,439 |
| Change in WC | $11,503 | $8,510 | -$20,381 | $1,983 |
| Other Non-Cash | $7,697 | -$2,167 | $20 | -$2,108 |
| Operating Cash Flow | $22,631 | $20,821 | -$6,036 | $24,365 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14,834 | -$9,263 | -$4,740 | -$7,567 |
| Net Acquisitions | $19 | -$18,726 | $0 | $0 |
| Inv. Purchases | -$58,474 | -$44,401 | -$48,431 | -$47,320 |
| Inv. Sales/Matur. | $54,900 | $44,000 | $36,300 | $60,650 |
| Other Inv. Act. | $0 | $12 | -$5,560 | $7 |
| Investing Cash Flow | -$18,389 | -$28,378 | -$22,431 | $5,770 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$31 | -$57 | -$26 | -$26 |
| Stock Issued | $77 | $19 | $18 | $373 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$965 | $139 | -$1,545 | -$5,732 |
| Financing Cash Flow | -$919 | $101 | -$1,553 | -$5,385 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $3,323 | -$7,456 | -$30,020 | $24,750 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $82,233 | $89,689 | $119,709 | $94,959 |
| End Cash | $85,556 | $82,233 | $89,689 | $119,709 |
| Free Cash Flow | $7,797 | $11,558 | -$10,776 | $16,798 |